| Bioactivity | DGKα-IN-7 is a DGKα inhibitor with the IC50 of 6.225 nM, extracted from patent WO2022271684 (compound 100). DGKα-IN-7 has the potential for cancer study. |
| Target | 6.225 nM (DGKα) |
| Name | DGKα-IN-7 |
| CAS | 2886092-50-6 |
| Formula | C23H17F5N6 |
| Molar Mass | 472.41 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Codelli, Julian A., Preparation of substituted triazoloquinazolines as diacylglycerol kinase modulators. WO2022271684 |